Capecitabine and Oxaliplatin（CAPEOX） combined with Sintilimab plus bevacizumab biosimilar（IBI305）for first-line treatment of advanced gastric or esophagogastric junction adenocarcinoma: study protocol of a single-arm, phase Ib/II trial
Research Square (Research Square)